-2%
Amlodipine + Olmesartan Medoxomil
- Treatment of hypertension
- Provides better blood pressure control than either component used alone
- Can be used alone or in combination with other antihypertensive agents
- May cause dizziness or drowsiness; avoid driving or operating machinery until you know how it affects you
- Rise slowly from sitting or lying positions to prevent lightheadedness
- Alcohol may enhance the blood pressure-lowering effect and should be avoided
- Ankle or foot swelling may occur; elevate legs and consult a doctor if persistent
- Not recommended during pregnancy or breastfeeding
Tenivasc 5/20 is a fixed-dose combination of Olmesartan Medoxomil and Amlodipine, designed to effectively control high blood pressure. Olmesartan is an angiotensin II receptor blocker (ARB), while Amlodipine is a calcium channel blocker (CCB). Together, they relax blood vessels, reduce vascular resistance, and help the heart pump blood more efficiently, leading to sustained blood pressure reduction.
Amlodipine inhibits calcium entry into vascular smooth muscle and myocardial cells, causing peripheral and coronary vasodilation and improving oxygen delivery to the heart.
Olmesartan Medoxomil selectively blocks angiotensin II (AT₁) receptors, preventing vasoconstriction and aldosterone secretion, thereby lowering blood pressure and improving blood flow.